Living Cell Technologies annual loss widens by a third on drug trial costs
By Rebecca Howard Aug. 24 (BusinessDesk) - Living Cell Technologies, the ASX-listed biotech company with New Zealand-based operations, said its full-year loss was 33 percent wider on higher costs associated with its latest drug trials. The Melbourne-based company reported...
Metro Performance Glass shares sink 10% on muted outlook
By Rebecca Howard Aug. 24 (BusinessDesk) - Metro Performance Glass shares fell 10 percent after the company said it expects its first half results to be largely flat despite the contribution from recently acquired Australian Glass Group. "Given the current conditions we are...
Scales shares down after first-half profit drops 14% after bad weather, reaffirms annual guidance
By Rebecca Howard Aug. 24 (BusinessDesk) - Scales Corp shares fell 5.8 percent after it said its first half profit fell 14 percent after its apple orchards were hit by heavy rain and winds and needed more expensive care. Net profit was $29 million, or 20.7 cents, for the s...
NZME first half earnings edge up 1%, though headwinds remain
By Rebecca Howard Aug. 24 (BusinessDesk) - NZME increased first half trading earnings 1 percent as audience numbers ticked up but warned that headwinds remain and said completing the merger with Fairfax Media remains a priority. Trading net profit was $9.9 million in the s...
Prev
